Merck saw the highest growth of 0.99% in patent filings in June and 1.84% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.75% and grants by 0.62%. GlobalData’s DataBook provides a comprehensive analysis of Merck‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Merck has been focused on protecting inventions in European Patent Office(EPO) with 101 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 26% filings and 18% grants. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Merck is filings its patents. Among the top granted patent authorities, Merck has 35% of its grants in United States(US), 18% in European Patent Office(EPO) and 9% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Merck
In terms of grant share, Merck stands in tenth position among its competitors. Roche and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to rare diseases and nanomedicine lead Merck's portfolio
Merck has the highest number of patents in rare diseases followed by, nanomedicine and climate change. For rare diseases, nearly 28% of patents were filed and 20% of patents were granted in Q2 2024.
Diabetes related patents lead Merck portfolio followed by other miscellaneous equipment, and pulmonary hypertension
Merck has highest number of patents in diabetes followed by other miscellaneous equipment, pulmonary hypertension, fibrosis, and human immunodeficiency virus (hiv) infections (aids). For diabetes, nearly 2% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Merck's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
